Literature DB >> 12854911

Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease.

Yelda Karincaoglu1, Emin Kaya, Muammer Esrefoglu, Ismet Aydogdu.   

Abstract

Chronic myeloid leukemia (CML) is a myeloproliferative disease arising from abnormal stem cells and associated with splenomegaly and leukocytosis. Hydroxyurea and interferon alpha are used in treatment very frequently. Behcet's disease (BD) is a chronic, repetitive disease of unknown etiology and associated with mucocutaneous, ocular, vascular and central nervous system involvement. Cases with symptoms of BD have been reported during interferon alpha treatment of CML. However, similar symptoms due to hydroxyurea treatment have been reported in only one case until now. A 32-year-old female patient under follow up because of CML and BD, developed a large genital ulcer during hydroxyurea treatment. Ulcers due to hydroxyurea treatment and the co-existence of these two diseases has been reported in only one case in the literature while large genital ulcers have not been reported previously.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854911     DOI: 10.1080/1042819031000067864

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

1.  Panuveitis simulating ocular Behçet's in cases of chronic myelogenous leukaemia in remission.

Authors:  Rohan Chawla; Koushik Tripathy
Journal:  BMJ Case Rep       Date:  2017-11-23

Review 2.  Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature.

Authors:  Soner Senel; Emin Kaya; Ismet Aydogdu; M Ali Erkurt; Irfan Kuku
Journal:  Rheumatol Int       Date:  2006-01-11       Impact factor: 2.631

Review 3.  [Ulcers following therapy with hydroxyurea. Three case reports and review of the literature].

Authors:  S Boneberger; R A Rupec; T Ruzicka
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

4.  miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.

Authors:  Mark P Boldin; Konstantin D Taganov; Dinesh S Rao; Lili Yang; Jimmy L Zhao; Manorama Kalwani; Yvette Garcia-Flores; Mui Luong; Asli Devrekanli; Jessica Xu; Guizhen Sun; Jia Tay; Peter S Linsley; David Baltimore
Journal:  J Exp Med       Date:  2011-05-09       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.